Lupin Ltd Corporate Actions

Lupin Secures FDA Nod for First-to-File Generic HIV Drug

 Copy Link

Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets are therapeutic equivalents of Symtuza Tablets 800 mg/150 mg/200 mg/10 mg brand of Janssen Products, LP.

Top Stocks for Today - 9th January 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Tata Motors, BHEL, Hindalco, Lupin, etc.

Lupin Acquires Huminsulin Brand from Eli Lilly to Boost Diabetes Portfolio

 Copy Link

Lupin was already selling Huminsulin under the license agreement entered with Lilly India.

Lupin gets USFDA approval for generic HIV tablets

 Copy Link

The approval enables Lupin to offer a generic version of Descovy pills, which were originally produced by Gilead Sciences Inc.

Top Stocks for today - 16th December 2024

 Copy Link

Here are some of the stocks that may see significant price movement today: Reliance Industries, Biocon, Bharat Forge, etc.

Lupin Q2 Profit Surges 74%, Revenue Up 12.6%

 Copy Link

Lupin ranks as the third-largest pharmaceutical player in the U.S. by prescriptions and seventh in the Indian Pharmaceutical Market (IPM).

Lupin Q1 Net Profit Jumps 77%, Shares Rise 5%

 Copy Link

Lupin Limited reports a 77% increase in Q1 net profit to ₹801.3 crores, with total sales up 16.3%.

Top 10 stocks for today – 7th August 2024

 Copy Link

Here are some of the stocks that may see significant price movement today: Tata Power, Chambal Fertilisers, Cummins India, etc.

Top 10 stocks for today – 06th August 2024

 Copy Link

Here are some of the stocks that may see significant price movement today: Adani Energy Solutions, Bharti Airtel, Bharti Hexacom, etc.

Lupin sells US women’s health business for $84 million

 Copy Link

According to the terms of the agreement, Lupin may receive up to $84 million in total payment based on future dependent milestones.